Presentation is loading. Please wait.

Presentation is loading. Please wait.

Supraventricular Arrhythmias AAT.A FLUTTER.A FIB

Similar presentations


Presentation on theme: "Supraventricular Arrhythmias AAT.A FLUTTER.A FIB"— Presentation transcript:

1 Supraventricular Arrhythmias AAT.A FLUTTER.A FIB
MEHDI BAKHSHI MSN PhD ICNS

2 Definition Rapid heart rhythm during which the electrical impulse propagates down the normal His Purkinje system similar to normal sinus rhythm Distinct from ventricular tachycardia which only originates in the ventricles

3 Mechanisms of Arrhythmia
Automaticity Enhanced automaticity Abnormal automaticity

4 Mechanisms of Arrhythmia
Triggered Activity Small depolarizations during or just after repolarization (phases 3 or 4) which can trigger a new depolarization.

5 Mechanisms of Arrhythmia
Reentry-most common mechanism Short circuit that forms between two “pathways” that are either anatomically or functionally distinct Typically: Path 1: Slow conduction, short refractory period Path 2: Rapid conduction, long refractory period

6 Reentry Panel A: Most impulses conduct down both pathways.
Panel B: Unidirectional block, due to longer refractoriness in one pathway. Panel C: Potential to have reentry back up the previously refractory pathway Panel D: Reentry then can persist.

7 Supraventricular Arrhythmias
Atrial arrhythmias (AT, AFL and AF) Atrioventricular nodal reentrant tachycardia (AVNRT) and junctional ectopic tachycardia (JET) Atrioventricular reentrant tachycardia (AVRT) Wolf-Parkinson-White Syndrome Orthodromic AVRT Antidromic AVRT

8 SVT: Symptoms May be variable
Palpitations, chest pounding, neck pounding Weakness/malaise Dyspnea Chest pain Lightheadedness Near syncope/syncope Symptoms usually abrupt in onset and termination May have history of symptoms since childhood or have a positive FHx

9 SVT: Physical Exam In absence of tachycardia, usually normal
Rapid heart rate ( ) May be irregular or regular (mechanism) BP may be low or with narrow pulse pressure Neck veins may reveal cannon waves.

10 Supraventricular Arrhythmias
Atrial arrhythmias (AT, AFL and AF) Atrioventricular nodal reentrant tachycardia (AVNRT) and junctional ectopic tachycardia (JET) Atrioventricular reentrant tachycardia (AVRT) Wolf-Parkinson-White Syndrome Orthodromic AVRT Antidromic AVRT

11 Sinus Rhythm Originates in sinus node (automaticity)
bpm resting Up to 200 bpm Conduction through normal AV axis P wave morphology reflects site of onset

12 Atrial Tachycardia Ectopic atrial focus 150-250 bpm 1:1 AV conduction
Reentrant, automatic or triggered bpm 1:1 AV conduction Paroxysmal or “warm up” P wave morphology variable

13 Focal Atrial Tachycardia
CSO IVC RAFW RAA LAA LAFW PV SN I A S CT * * * SVC

14 20 yr woman with post-partum congestive heart failure
II III aVR aVL aVF V1 V2 V3 V4 V5 V6

15 Adenosine Injection I II III aVR aVL aVF V1 V2 V3 V4 V5 V6

16 Atrial Flutter Reentrant circuit localized to the RA 250-350 bpm
2:1 or variable AV block Classic “saw-tooth” P waves

17 Activation on Halo Catheter
Typical = Counterclockwise V1 II aVF TA 19,20 TA 1,2 TA 9,10 TA 3,4 TA 5,6 TA 7,8 CS Os TA 9,10 TA 1,2 TA 11,12 TA 13,14 TA 17,18 TA 19,20 CS Os

18 Activation on Halo Catheter
Atypical = Clockwise II aVF V1 CS Os TA 1,2 TA 3,4 TA 5,6 TA 7,8 TA 9,10 TA 11,12 TA 13,14 TA 17,18 19,20 TA 19,20 TA 9,10 CS Os TA 1,2

19 Atrial Fibrillation Chaotic atrial rhythm due to multiple reentrant wavelets bpm Ventricular rate irregular and rapid due to variable AV block HTN, valvular dz., metabolic dz., CMP,

20 Atrial Fibrillation The rapid atrial activity results in:
Increased risk of thrombus formation and stroke Rapid and irregular ventricular rate The treatment is aimed at: Decreasing the risk of stroke (coumadin, ASA) Decreasing the ventricular rate (beta-blockers, calcium channel blockers, digoxin) Restoring the rhythm to sinus (drug therapy, catheter ablation, surgical Maze)

21 Atrial Fibrillation Advantages of rhythm control:
Abolition of symptoms Halting atrial enlargement Improvement in left ventricular function and exercise capacity Disadvantages of rhythm control: Subjecting patients to drug therapy and/or procedure that might be associated with complications

22 Atrial Fibrillation Treatment
In patients with minimal symptoms and normal left ventricular function: Coumadin/ASA Rate control (drugs, AVJ ablation + BV pacing) In patients with significant symptoms and/or left ventricular dysfunction: Rhythm control (anti-arrhytmic drugs, catheter ablation)

23 Drug Therapy to Maintain Sinus Rhythm in Patients with Recurrent Paroxysmal or Persistent Atrial Fibrillation ACC/AHA/ESC Guidelines Heart Disease No (or minimal) Yes Heart Failure CAD Hypertension Flecainide Propafenone Sotalol LVH greater than or equal to 1.4 cm Amiodarone Dofetilide Sotalol Amiodarone Dofetilide Amiodarone, Dofetilide Yes No The recommendations for drug therapy for patients with recurrent paroxysmal or persistent AF are presented in this slide. For patients with no (or minimal) heart disease, therapy should begin with flecainide, propafenone, or sotalol. If these drugs do not prove to be effective, amiodarone or dofetilide may be initiated. If AF persists, treatment with disopyramide, procainamide, or quinidine may be attempted. Nonpharmacological options may also be considered at this point. The presence of heart disease incurs a higher risk of adverse events with the use of antiarrhythmic agents and therapy must be tailored to the type of heart disease present and data in the medical literature regarding safety. For patients with heart failure, amiodarone and dofetilide are the drugs of choice. For patients with CAD, a first attempt should be made using sotalol, followed by amiodarone and dofetilide. Disopyramide, procainamide, or quinidine may be used in these patients if the more appropriate drugs fail. Hypertensive patients with LVH 1.4 cm can be treated with amiodarone. The first choice for hypertensive patients with LVH <1.4 cm is flecainide, propafenone, followed by amiodarone, dofetilide or sotalol. If AF persists, these patients can be treated with disopyramide, procainamide or quinidine. Flecainide Propafenone Disopyramide Procainamide Quinidine Disopyramide Procainamide Quinidine Consider nonpharmacological options Amiodarone Dofetilide Sotalol Amiodarone Fuster et al. J Am Coll Cardiol. 2001;38: Disopyramide, Procainamide, Quinidine Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation.) J Am Coll Cardiol. 2001;38:

24 Atrial Fibrillation Catheter Ablation
Ablate PV potentials PV Isolation Pappone (circumferential LA ablation)

25 Supraventricular Arrhythmias
Atrial arrhythmias (AT, AFL and AF) Atrioventricular nodal reentrant tachycardia (AVNRT) and junctional ectopic tachycardia (JET) Wolf-Parkinson-White Syndrome Orthodromic AVRT Antidromic AVRT Atrial fibrillation with preexcitation

26 AV Nodal Reentrant Tachycardia
Morphology and location of P wave relative to QRS distinct

27 27 y.o with palpitations Does seeing the next ECG help you

28 Pseudo R’ in V1 during tachycardia
NSR AVNRT

29 Junctional Ectopic Tachycardia

30 Normal sinus rhythm Junctional tachycardia

31 Supraventricular Arrhythmias
Atrial arrhythmias (AT, AFL and AF) Atrioventricular nodal reentrant tachycardia (AVNRT) and junctional ectopic tachycardia (JET) Atrioventricular reentrant tachycardia (AVRT) Wolf-Parkinson-White Syndrome Orthodromic AVRT Antidromic AVRT

32 Wolff-Parkinson-White Syndrome
Second electrical connection exists between the atria and ventricles (accessory pathway) Resemble atrial tissue Results in a short PR and Delta wave (pre-excitation) Some AP conducts only retrograde (concealed)

33 Arrythmias in WPW The most common arrhythmia is orthodromic AV reentrant tachycardia (narrow QRS) Less common are pre-excited tachcyardias (wide QRS) Antidromic AV reentrant tachycardia Atrial tachycardia/flutter with pre-excitation AVNRT with pre-excitation Atrial fibrillation with pre-excitation (most life threatening due to rapid ventricular response)

34 Orthodromic AVRT Conduction down AV axis during tachycardia gives NARROW QRS complex

35 Pre-excited Tachycardia
Mechanisms AT AVRT AVNRT Conduction down AP during tachycardia gives WIDE QRS complex

36 Atrial Fibrillation

37 RF Ablation in WPW

38 Supraventricular Arrhythmias
Atrial arrhythmias (AT, AFL and AF) Atrioventricular nodal reentrant tachycardia (AVNRT) and junctional ectopic tachycardia (JET) Atrioventricular reentrant tachycardia (AVRT) Wolf-Parkinson-White Syndrome Orthodromic AVRT Antidromic AVRT

39 SUMMARY Mechanisms of SVT Atrial Tachycardia AVNRT AVRT SP FP
Predictions about V:A time for DDX Circuits require two pathways with different conduction vel and different refractory periods Atrial Tachycardia AVNRT AVRT

40 Differential Diagnosis of NCT
Short RP AVRT AT Slow-Slow AVNRT Long RP AT Atypical AVNRT PJRT P buried in QRS Typical AVNRT AT JET

41 SUMMARY Obtain a 12 lead ECG. The location of the P wave will dictate the differential diagnosis If hemodynamically unstable (chest pain, heart failure, hypotension) CARDIOVERSION If hemodynamically stable AV NODAL AGENT Long term therapy depends on mechanism and can be conservative, pharmacologic or invasive EP study often needed for definitive characterization of mechanism and can cure most SVTs with 90% success rate


Download ppt "Supraventricular Arrhythmias AAT.A FLUTTER.A FIB"

Similar presentations


Ads by Google